Supply Chain

Eli Lilly conducted human trials of a drug to treat osteoarthritis pain, which found the drug lacked efficacy. Researchers at the Linda and Jack Gill Center for Biomolecular Science at Indiana University in Bloomington, however, have found the compound blocks…

On Feb. 26, Boston Scientific completed a $1 billion public offering of 4 percent interest rate senior notes due March 1, 2028.

Motus GI's colonoscopy preparation system Pure-Vu received European CE mark approval.

Biolase entered a non-binding agreement to exclusively market and sell S-Ray's ClearView Scan, an ultrasound-based intraoral imaging system. Here are five highlights.

Xenco Medical aims to lower costs by packaging surgical instruments and implants together in sterile, single-use systems, according to Packaging Digest. Here are four things to know.

A Gretna, La.-based physician accused of running a "pill mill" who earned nearly $14 million from his 10-year operation between has surrendered his medical license, according to the DEA.

Despite lower revenues, the Motley Fool argues Valeant Pharmaceuticals CEO Joseph Papa is sticking to his mission of selling off noncore assets to help Valeant pay down its debt.

The FDA is contemplating changing its medical device for software approval process, JD Supra reports.

NN, an industrial manufacturer with 36 facilities worldwide, acquired Bridgemedica, Medical Design and Outsourcing reports. Here are three insights:

With news that Amazon is entering the pharmaceutical business, Cardinal Health's CFO Jorge Gomez said the company isn't worried about any potential threats to its customer base, The Street reports.